WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
Available in English, Spanish, French, Arabic , Chinese and Russian
Large File. Please download directly from the website
An Interactive Version of the English, French and Spanish Version is available, too.
Disponible en anglais, espagnol, français, arabe, chinois et russe
Disponible en inglés, español, francés, árabe, chino y ruso
Доступно на английском, испанском, французском, арабском, китайском и русском
Diabetes Care2018;42(Suppl. 1):S1–S194.
Translated and adapted from the original English Antiretroviral drugs chart by the East Europe and Central Asia Union of People Living with HIV (ECUO). This resource shows drugs currently available in the Eastern Europe and Central Asia area.
Last update Oct. 2018
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
Guidelines giving advice for the provision of general anaesthesia in sites remote from a main theatre facility.
Summary chart of recommendations on medical management of abortion